Trials / Conditions / Autosomal Dominant Hypocalcemia (ADH)
Autosomal Dominant Hypocalcemia (ADH)
3 registered clinical trials studyying Autosomal Dominant Hypocalcemia (ADH).
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Active Not Recruiting | Efficacy and Safety of Encaleret Compared to Standard of Care in Participants With ADH1 NCT05680818 | Calcilytix Therapeutics, Inc., a BridgeBio company | Phase 3 |
| Completed | Safety, Tolerability, and Efficacy of Encaleret in Participants With Autosomal Dominant Hypocalcemia (ADH) Typ NCT04581629 | Calcilytix Therapeutics, Inc., a BridgeBio company | Phase 2 |
| Completed | A Study to Determine the Effects of NPSP795 on the Calcium-sensing Receptor in Subjects With Autosomal Dominan NCT02204579 | Shire | Phase 2 |